Question 1

Why is computational prediction insufficient?

Accepted Answer

Similarity search finds sites resembling the target, but chromatin accessibility, local sequence context and mismatch position all influence whether cutting actually occurs. Prediction therefore nominates many sites that never cut and misses real ones, particularly those involving small insertions or gaps in the pairing. Experimental nomination is required alongside it.

Question 2

Which unbiased nomination method should be used?

Accepted Answer

Cell-free cleavage of purified genomic material is highly sensitive and casts wide, though it ignores chromatin and overcalls. In-cell methods that capture a tag at break sites reflect the real context but detect fewer rare events. Using one of each, then verifying the union by targeted sequencing, is the defensible pattern.

Question 3

What read depth does verification require?

Accepted Answer

Depth sets the detection limit, and sequencing error places a floor beneath which real low-frequency events cannot be distinguished. Calculate the frequency your depth can resolve, state it, and use unique molecular identifiers where very low frequencies matter. A negative result means nothing without the limit attached.

Question 4

How do high-fidelity enzyme variants work?

Accepted Answer

Engineered variants weaken non-specific contacts with the genome so that mismatched pairing releases before the cutting step proceeds. Specificity improves substantially, sometimes with reduced activity at the intended site, so both must be measured together. Guide sequence influences how much benefit a given variant provides.

Question 5

How does delivery format influence specificity?

Accepted Answer

Preassembled protein and guide complexes act quickly and disappear, limiting total exposure, whereas continuously expressed constructs keep cutting for days and accumulate unintended events. Report the format, dose and time of analysis, since the same guide can look precise or promiscuous depending on these choices alone.

Question 6

What larger genomic changes are commonly missed?

Accepted Answer

Amplicon panels around predicted sites cannot see loss of long segments spanning the cut, rearrangements joining two cut sites, whole chromosome arm changes or integration of vector sequence. Long-read sequencing, karyotype-level analysis and copy number methods are needed, and these outcomes matter greatly for therapeutic proposals.

Question 7

How should guides be chosen to reduce risk?

Accepted Answer

Prefer guides with few close genomic competitors, and weigh where those competitors sit, since a site inside a growth-controlling gene carries more risk than one in a gene desert. Test several guides experimentally rather than selecting on predicted score alone, because measured specificity varies widely among similarly scored candidates.

Biotechnology

Biotechnology

Research Frontiers in CRISPR Off-Target Effects Mitigation